Don’t let the high cost of brand twice-daily LABA/LAMA inhaler disrupt your COPD care. We help eligible patients access Bevespi Aerosphere (glycopyrrolate/formoterol) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
Bevespi PAP for COPD.
Eligibility verification.
AffordMyPrescriptions eliminates that burden. $69.95/month advocacy.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$580 | Save substantially |
| CVS Pharmacy | ~$600 | Save substantially |
| Walmart | ~$420 | Save substantially |
| Costco | ~$410 | Save substantially |
Generic Anoro Ellipta | ~$80/mo | Once-daily generic |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
Generic Anoro Ellipta once-daily LABA/LAMA much cheaper.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Bevespi Aerosphere:
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Bevespi Aerosphere assistance.
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Bevespi combines glycopyrrolate (LAMA) + formoterol (LABA) — twice-daily metered-dose inhaler for COPD maintenance. Co-suspension technology delivers both drugs through HFA propellant.
How Bevespi Aerosphere Works:
Dual bronchodilation — LAMA + LABA mechanisms.V
Twice-daily MDI dosing. Co-suspension porous particle technology. Once-daily LABA/LAMA options (Anoro Ellipta, Stiolto Respimat) often preferred for adherence.
Form and use:
Bevespi 2 inhalations BID.
Generic availability:
No generic Bevespi. Generic Anoro Ellipta (umeclidinium/vilanterol — once daily, dry powder) cheaper. Stiolto Respimat (tiotropium/olodaterol — once daily). Duaklir Pressair (aclidinium/formoterol — twice daily, dry powder).
Warnings:
LABA class warning, cardiac effects, paradoxical bronchospasm, narrow-angle glaucoma, urinary retention, hypersensitivity, oral candidiasis with MDI (rinse mouth).
Bevespi $400–$600. Generic Anoro $80/month.
Once-daily Anoro/Stiolto better adherence. Bevespi BID. Choice depends on patient preference, technique, insurance.
Bevespi MDI requires coordination/spacer often helpful. Dry powder (Anoro Ellipta) requires inspiratory flow. Patient-specific factors.
Generic Anoro Ellipta once-daily cheaper.
Generic Anoro Ellipta cheaper LABA/LAMA. Check eligibility today.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.